A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Clinical trial NCT03912233 · COMPLETED
Trial details
- NCT number
- NCT03912233
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2019-12-10
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.